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3. ABSTRACT
The  aim  of  this  thesis  was  to  study  the  substrate  specificity  of  A-type  phospholipases  (PLAs)  that  belong  to
different sub-families in order to understand the key factors that regulate their activity. The experimental part of
this thesis consists of three studies each one focusing on PLAs that belong to a specific subgroup. In the first study,
we  developed  a  mass-spectrometric  (MS)  assay  and  implemented  it  to  study  in  detail  the  effect  of  acyl  chain
length and unsaturation of glycerophospholipids (GPLs) on their hydrolysis by three different secretory PLA 2s
(sPLA2s) from various sources. The key finding of this study was that efflux of the GPL substrate from the bilayer
largely determines the rate  of  hydrolysis  by these PLAs.  In micelles,  accommodation of  the GPL acyl  chains in
the  catalytic  active  site  seems  to  be  more  important  for  substrate  specificity.  In  the  next  study  we  used  the  MS
assay developed in study I,  to  investigate  whether  substrate  efflux propensity regulates  the activity  of  the Ca 2+ -
independent PLA-Beta (iPLAβ). Our results strongly suggest that the activity of iPLAβ is also determined by the
efflux of the GPL substrate from the membrane bilayer. Our last study was on the cytoplasmic PLA-alpha
(cPLA2α) that has been implicated in the initiation of the inflammatory lipid-mediator cascade generating
eicosanoids and platelet-activating factor. The study was carried out to understand to what extent accommodation
in the catalytic  site  determines specificity  for  arachidonic acid (AA) and if  efflux propensity plays a  role  in  the
substrate specificity of cPLA2α. Our results indicate that while accommodation of the substrate in the active site
greatly contributes to the preferential hydrolysis of AA-containing GPLs by cPLA2α, efflux of the substrate from a
membrane bilayer also plays a significant role. In summary, these studies not only provide information on the
factors  regulating  the  substrate  specificity  of  various  PLAs  but  also  indicate  that  lateral  arrangement  of  GPLs
could be a key regulator of homeostatic PLAs like iPLAβ.
14. INTRODUCTION
GPLs constitute the major structural lipids in nearly all biological membranes. Typical GPLs consist of a glycerol
backbone with varying phosphate containing polar head groups esterified to its sn-3 position and an acyl chain
moiety of varying lengths esterified to the sn-1 and sn-2 positions resulting in a complex repertoire of >1000
distinct molecular species. Depending on the structure of the polar head group, GPLs are categorized into various
classes, the major ones being phosphatidylcholines (PC), phosphatdiylethanolamines (PE), phosphatidylserines
(PS) and phosphatidylinositols. Each class in turn consists of a variety of molecular species varying in their fatty
acid composition. GPLs are amphipathic that causes them to spontaneously assemble into a bilayer membrane in
an aqueous medium. The membranes help in maintaining the integrity of the cell or the organelles by creating a
semi-permeable boundary between the outside and inside. In addition, GPLs are also involved in intracellular
signaling and membrane trafficking (64, 79, 128 and 312). Although many aspects of GPL metabolism have been
established, it is still poorly understood how mammalian cells maintain the relative concentrations of the different
GPL classes within close limits. A-type PLAs form a ubiquitous class of enzymes that catalyze the hydrolysis of
fatty acids either at the sn-1 or sn-2 position of the GPL glycerol moiety, thus producing a lyso-GPL and a free
fatty acid. Earlier studies have shown evidence that cells contain A-type PLAs that selectively degrade GPLs that
are present "in excess" (206, 222). However, the identity of these enzymes is still elusive. Recent data suggest that
select  members  of  the  Ca2+ -independent  (iPLA)  subfamily,  in  particular  iPLAβ and  iPLAδ are  involved  in
membrane GPL homeostasis (19, 50, 96 and186) but there is little information on what regulates the activity of
these putatively homeostatic PLAs. In the present study, we developed a high-throughput mass spectrometry-
based assay and used it to study the substrate specificities of various A-type PLAs in an unprecedented detail in
order to determine the factors that contribute to the specificity of these enzymes.
25. REVIEW OF THE LITERATURE
5.1 Processes maintaining GPL homeostasis in mammalian cells
GPL homeostasis  is  crucial  for  the survival  of  mammalian cells  as  indicated by the fact  that  they maintain GPL
class compositions of their membranes within close limits (282, 290). The key cellular processes that contribute to
membrane GPL homeostasis in mammals are biosynthesis, acyl chain remodeling and degradation. Each of these
will now be briefly discussed.
5.1.1 Biosynthesis
Fig 1. gives an overview of the biosynthetic routes for the production of different classes of GPLs.
Figure 1. Pathways of GPL synthesis in mammalian cells. Key metabolites are represented in purple and the
enzymes in the reactions are in orange.
35.1.1.1 Biosynthetic pathways of GPLs
Phosphatidic acid (PA), the common precursor of all GPLs, is the first intermediate that is synthesized de novo
from glycerol-3-phosphate (G-3-P) through the sequential acylation of the sn-1 and sn-2 hydroxyl groups by acyl-
CoA:glycerol-3-phosphate acyltransferase (GPAT) and lysophosphatidic acid acyl transferase (LPAAT)
respectively (12, 46, 229, 246, 247 and 266). PA can also be synthesized from DAG upon its phosphorylation by
the enzyme diacyl glycerol kinase (DAGK) (45, 273). An alternative route, through the acylation of
dihydroxyacetone-P and the subsequent reduction of acyl-dihydroxyacetone-P to lyso-PA also contributes to PA
synthesis (60, 102, 161). PA serves as a branching point for the synthesis of various classes of GPLs through two
pathways. In one branch, PA is converted to CDP-diacylglycerol by CDP-diacylglycerol synthase (CDS) for the
formation of PI, PG and CL as the principal products (73). In the other branch, dephosphorylation of PA by
phosphatidate  phosphatase  (PAP)  yields  DAG  that  serves  as  an  intermediate  precursor  for  PC  and  PE via the
CDP-choline or the CDP-ethanolamine pathway, respectively (38, 39, 56). Alternatively, PE is derived from PS -
mediated decarboxylation (191, 287, 292). PS is produced via a Ca2+-dependent base-exchange reaction by PSS1
or PSS2 in which serine replaces the existing head group of PC and PE respectively (159, 160, 294).
5.1.1.2 Regulation of Biosynthesis of PC
In mammals, PC is synthesized via two  pathways,  the  CDP-choline  pathway  in  all  the  tissues  or  the  PEMT
(phosphatidylethanolamine N-methyltransferase) pathway in the liver (94, 284, 285). The CDP-choline pathway
consists of 3 steps: First, choline is phosphorylated in an ATP -dependent manner by choline kinase (CK-α or CK-
β) (8, 307). Under certain conditions, this step might be rate-limiting in PC synthesis (133, 134, 206). In the
second step, the enzyme CTP: phosphocholine cytidylyltransferase (CT) facilitates the conversion of
phosphocholine to CDP-choline (264, 313). Two mammalian isoforms of CT (CT-α, CT-β) exist, encoded by
Pcyt1a or Pcyt1b respectively (267, 145). CT-α is a soluble protein that is present both in the cytoplasm as well as
in the nucleus; it contains a nuclear localization sequence (NLS) (55, 125, 149 and 178). The CT-β variant lacks
the NLS, so it has been found only in the cytoplasm (148, 178, 298). Global deletion of Pcyt1a in mice resulted in
embryonic lethality (297), on the other hand tissue specific Pcyt1a inactivation especially in lung (270), liver
(137), macrophages (314) or B-lymphocytes (80) did not seem to have a lethal effect. CT-β knockout mice grow
normally, but display gonadal deformation resulting in sterility (136, 145). Another study showed that Pcyt1b
disruption caused impairment in axon branching (286). Collectively these results suggest that CT-α has a more
dominant role in PC synthesis than CT-β. In the final step, the phosphocholine moiety is added to a diacylglycerol
moiety in a reaction catalyzed by CDP-choline: 1, 2-diacylglycerol cholinephosphotransferase (CPT) (189). In
humans, two genes coding for enzymes with CPT activity have been identified i.e. CPT1 and CEPT1. The former
encodes for a CDP choline specific enzyme (CPT) while the latter encodes for CEPT that has specificity for both
CDP-choline as well as CDP-ethanolamine (113, 114).
4The PEMT pathway is primarily found in the liver (285). PEMT is an intrinsic membrane protein that catalyzes
three sequential reactions through which PE is converted to PC (284). The PEMT pathway and the CDP-choline
pathway might be reciprocally regulated (57, 295). The PEMT pathway contributes to ~30% of the PC
synthesized in the liver, when there is a limited supply of choline (67, 263, 284). It has also been suggested that
this pathway is critical in lipoprotein synthesis as it provides PC for VLDL formation (208-210, 284). PEMT -/-
mice survive and grow normally, however if they are fed a choline-deficient diet, the liver fails and mice die
within three days (172).
Previous studies have proposed that regulation of CT activity, the rate-limiting enzyme in PC biosynthesis, is
modulated by a physical property of the lipid membrane leaflets termed curvature elastic stress or membrane
torque tension which depends on the membrane lipid composition (59, 253). Indeed the activity of CT-α increased
with increasing elastic stress in agreement with this model (14). However, there is no evidence that curvature
elastic stress can regulate other biosynthetic enzymes or homeostatic PLAs.
5.1.1.3 Regulation of Biosynthesis of PE
The CDP-ethanolamine pathway is analogous to the CDP-choline pathway and consists of three enzymatic steps.
In the first step, ethanolamine kinase (EK1/EK2) catalyzes ATP -dependent phosphorylation of ethanolamine, thus
producing phosphoethanolamine (8, 181, 269). In the next step, phosphoethanolamine reacts with cytidine
triphosphate (CTP) to form CDP-phosphoethanolamine (CDP-EA) through the action of the cytosolic protein
CTP:phosphoethanolamine cytidyl transferase (ET) (16, 32). Very little is known about the regulatory mechanism
of the CDP-ethanolamine pathway. Disruption of the gene encoding ET, (pcyt2) resulted in embryonic lethality in
mice (89). Mice heterozygous for pcyt2 accumulated fat both in the liver and the adipose tissue due to increased
lipogenesis and reduced utilization of fat as a source of energy (89). Further, liver-specific ET knockout in mice
resulted in normal growth, however defects in hepatic lipid metabolism was observed (168). This reaction is
considered to be the rate-limiting step in the Kennedy pathway (32,  263).  In  the final  step,  CDP-EA reacts  with
DAG catalyzed by the enzyme CDP-ethanolamine diacylglycerol ethanolamine phosphotransferase (EPT1) to
yield the end product PE (113, 114).
The decarboxylation pathway is considered to be the major route for synthesis of PE species with a
polyunsaturated acyl chain at the sn-2 position (35, 288, 291). PS is first transported from its site of synthesis to
the inner mitochondrial membrane (IMM), where phosphatidylserine decarboxylase (PSD) catalyzes the
decarboxylation reaction to form PE. This transportation of PS from one organelle to another is considered to be
the rate-limiting step in the PSD pathway (111, 293). However the precise mechanisms involved in this process
still remain to be elucidated. Deletion of pisd, the gene encoding for PSD in mice, results in their death between
8-10 days of embryonic development (255). In PSD-deficient cells, mitochondria appear to be fragmented,
5abbarently shaped and diffuse, indicating reduced levels of mitochondrial PE thus being the cause for an
impairment in mitochondrial development (255). All these data suggest that the PSD pathway is crucial for
normal development.
5.1.1.4 Regulation of Biosynthesis of PS
In  mammalian  cells,  PS  is  synthesized  from  either  PC  or  PE  through  a  base-exchange  reaction  catalyzed  by
phosphatidylserine synthases, PSS1 or PSS2 (288, 289). Both these proteins are localized in ER domains in close
association with the mitochondrial membrane (MAM) (258). Over-expression studies have shown that PSS2, but
not PSS1, is subject to product (PS) inhibition (9). Incubation of CHO cells with exogenous PS vesicles inhibited
both the synthetizing enzymes (159). In vitro assays showed that purified PSS1 but not PSS2 was resistant to
product inhibition for reasons unknown (271). Disruption of genes encoding PSS1 and PSS2 in mice were shown
to cause death in-utero, in contrast mice lacking either one of them did not have any obvious defects (9, 29).
5.1.1.5 Regulation of Biosynthesis of PI and PG
Two  steps  are  involved  in  the  synthesis  of  PI.  In  the  first  step,  CDP-diacylglycerol  synthase  (CDS1  or  CDS2)
catalyzes the generation of CDP-diacylglycerol (CDP-DAG) from PA and CTP (110, 243). In the next step,
condensation of myo-inositol with CDP-DAG is catalyzed by PI synthase (PIS), an ER associated protein (7).
Studies by Imai and Gershengorn have shown that PI synthase activities might be subject to product inhibition. PI
synthesis  was  strongly  inhibited  up  to  84  to  91%  when  the  ER  and  PM  from  rat  pituitary  GH3  cells  were
incubated with exogenously added PI. Similar inhibition was observed when the PI content in intact cells was
increased  (131).  When  CDS1  and  PIS  were  over-expressed  in  COS-7  cells,  a  25-  and  8-  fold  increase  in  their
activities  was observed,  however  there was no significant  enhancement  in  PI  synthesis  and at  the same time the
cellular content of both PI and CDP-diacylglycerol did not increase as well (180).
In  PG  synthesis,  PGP  synthase  (PGPS)  first  catalyzes  the  committed  step  by  combining  G-3-P  and  CDP-DAG
thus resulting in the formation of phosphatidylglycerol phosphate (PGP). In the second step, PGP is
dephosphorylated by PGP phosphatase (PGPS) to form PG (148, 290). Reduced PGPS activity in CHO cells
resulted in a 90% decrease in PG content and an impairment of mitochondrial morphology and function (212,
213). PGPS could be a rate-limiting enzyme in PG synthesis based on the observation that upon its over-
expression in CHO cells, there was a 2.5-fold increase in cellular PG content (147).
5.1.2 Acyl chain remodeling in GPLs
The newly synthesized GPLs (PC and PE) through the de novo pathways typically possess a saturated fatty acid at
the sn-1 position and a mono- or a di-enoic fatty acid at the sn-2 position (281). In the following step, one or both
acyl residues can be exchanged in for others in a reaction (remodeling) catalyzed by a combination of multiple
6enzymatic activities through PLAs, lysophospholipid acyl transferases (LPLATs) and transacylases (120, 165,
236). Acyl chain remodeling takes place through two routes. Route 1 involves PLAs and acyl transferases and
route 2 involves transacylases.
5.1.2.1 Remodeling through route 1
In this route, fatty acid incorporation into GPLs is dependent on the availability of lyso-GPL acceptors maintained
by the continuing action of a multitude of PLAs, of which not many have been identified. However iPLAβ has
been thought to be involved in GPL remodeling (17, 20, 21, 43 and 301). In addition, the Group VIB Ca 2+-
independent PLA2-gamma (iPLA2γ) has been implicated in this process (196). Yet another PLA possibly involved
in GPL remodeling is cPLA2γ (11, 157, 256).
The key pathways involved in the incorporation of fatty acids into the glycerol backbone of GPLs are the acyl-
CoA:glycerol-3-phosphate (GP) acyl transferase and acyl-CoA:1-acyl-GP acyl transferase systems for de novo
synthesis (124, 164, 244) both of which show strict fatty acid specificity (3, 10, 118 and 144). A number of acyl
transferases (LPLATs) incorporate PUFAs into the sn-2 position of lyso-GPLs which act as acceptors. For
instance, lyso-PC acyltransferase (LPCAT1) incorporates saturated fatty acids such as 16:0 into PC to form
disaturated PC, a component of pulmonary surfactant (49, 204). LPCAT2 incorporates 20:4 into PC to form
platelet-activating  factor  and  its  precursor  (245).  LPCAT3 exhibits  a  broad  substrate  specificity  i.e.  PUFAs  like
18:2 and 20:4 are incorporated into PC, PE and PS (121, 188, 311 and 316). LPCAT4 preferentially incorporates
18:1(n-9) into PC and PE (121). Lyso-PI acyltransferase1 (LPIAT1) is unique in that it incorporates 20:4 into only
PI (167). The finding that LPCAT3 is a major acyltransferase that incorporates unsaturated fatty acids such as
18:1(n-9), 18:2 and 20:4 into PC, suggests that it has a major role in determining the level of GPL unsaturation.
The rapid turnover of sn-2 acyl  moiety of  GPLs was described by Lands as  a  remodeling pathway (164) and is
attributed  to  the  concerted  activation  of  PLAs  and  LPLATs  (81,  202).  Recently,  another  LPLAT family  distinct
from the other  LPLAT families  has been identified (121).  These enzymes do not  possess  the LPAAT motif.  The
key enzymes that exist under this category are: mLPCAT3, mLPCAT4 and mLPEAT1. MLPCAT3 acylates LPC,
LPE and LPS to PC, PE and PS respectively with polyunsaturated acyl CoA's (18:2 and 20:4). mLPCAT4 has
LPCAT and LPEAT activities preferring oleoyl-CoA (18:1) and then finally mLPEAT1 shows LPEAT and LPSAT
activities preferring oleoyl-CoA (18:1) (122).
5.1.2.1 Remodeling through route 2
Along route 2, acyl chain exchange (remodeling) is carried out by either the CoA-dependent or the CoA-
independent transacylation reactions wherein a GPL serves as an acyl chain donor and a lyso-GPL as an acceptor
(62, 309). In a CoA-dependent transacylation process, mainly 20:4, 18:2 or 18:0 containing acyl chain of a GPL is
transferred to an LPC acceptor in the presence of CoA (309). Studies with the 18:0 specific CoA-T transacylase
7showed that it has a restricted acyl donor specificity by using PA or PI but not PE or PS (123). On the other hand,
CoA-independent transacylation (CoA-IT) catalyzes transfer of long chained fatty acids (C20, C22) that are
polyunsaturated from a donor GPL to an ether bond containing lyso-GPL in the absence of any cofactors (such as
CoA) leading to the formation of alkylacyl-PC, alkylacyl-PE or alkenylacyl-PE (33, 53, 54).
5.1.2.2 Phospholipases (PLAs)
PLAs  are  classified  based  on  their  site  of  attack  on  the  GPL that  could  either  be  hydrolysis  of  the  1-acyl  ester
(PLA1) or the 2-acyl ester (PLA2) (235). PLAs that can hydrolyze both the acyl chains are called PLA-B (61, 288).
Other classes of PLA exist, that could cleave the glycerophosphate bond (PLC) or the base group (PLD) (76, 261).
Both these enzymes are called phosphodiesterases. Finally, there are enzymes called lyso-PLAs that can catalyze
the removal of the acyl chain from monoacyl(lyso)-GPLs (18, 279, 280).
PLCs induce breakdown of GPL by hydrolyzing the bond between phosphate and the glycerol backbone to form
the phosphorylated head group and sn-1,2-diacylglycerol (DAG) that further goes on to activate protein kinase C
(PKC) (30, 207). In all, mammalian PLCs that are involved in inositol lipid signaling pathways constitute 13
members that are classified into 6 isotypes (88, 261) based on their structures. Other studies have revealed that
unknown players carry out PLC -mediated hydrolysis of PC and PE which in a way is tempting to implicate them
in GPL homeostasis (31, 72, 77, 78, 242, 306 and 315). Sphingomyelin synthases (SMS1 and 2) represent another
class of enzymes that enable the transfer of a phosphocholine moiety from PC onto ceramide to produce
sphingomyelin and diacylglycerol (DAG). SMS1 localizes at the Golgi while SMS2 localizes both at the Golgi
and the plasma membrane (260).
Mammalian PLDs are ubiquitous in nature (141). They preferentially hydrolyze PC or PE to yield PA and free
choline or ethanolamine respectively (22, 234, 265). Mammalian cells harbor two isoforms of PLD: PLD1 and
PLD2 both of which contain two HKD motifs that are critical for enzymatic catalysis (217). The PLD pathway
has been implicated in the regulation of insulin signaling, extracellular Ca2+ entry into the cells and PI4P 5-kinase
activation of mTor amongst others (86, 141, 203). Although in principle, members of the PLD family could be
involved in GPL homeostasis, there is hardly any evidence for this.
Regarding degradation, several studies have provided evidence that PLAs are key players in this process (15, 25,
91, 115, 196, 283 and 302). PLAs are ubiquitous in nature and have diverse roles to play from membrane
homeostasis, lipid mediator production to signal transduction (41). They vary in the site of action on the GPLs,
physiological function, mode of action and finally regulation (41, 48, 163).
85.1.3 Coordination of synthesis and degradation
Although it is clear that GPL homesostasis is maintained through the precise coordination of GPL biosynthesis
and degradation, it is quite unclear how this is accomplished. Such coordination is essential in order to avoid futile
competition between these opposing processes. Strong support for strict coordination, comes from studies
demonstrating that enhancing the synthesis of a GPL class increased its degradation in proportion. In one study,
over-expression of cytidylyl-transferase (CT) in HeLa cells led to an increase in the synthesis of PC by 4-5 fold,
but no significant increase in the PC content was observed, rather the content of GPC, the deacylation product of
PC greatly increased (15, 296). A similar outcome was observed in case of PS and PE (179, 257). Conversely,
inhibition of synthesis of a GPL, inhibited its degradation as well obviously to maintain GPL homeostasis. For
instance, when the synthesis of PE was inhibited by mutating the rate-limiting enzyme: ethanolamine
phosphotransferase (EPT), the PE content of the cells did not decrease due to its reduced degradation (222). These
data demonstrate that in mammalian cells, GPL synthesis and degradation are coordinated, and provide strong
evidence that the cells contain homeostatic PLAs that selectively degrade the GPL species when produced in
excess. Mammalian cells express numerous A-type PLAs (41, 198) and those involved in GPL homeostasis have
not been firmly established. Some studies have indicated that members of the Ca 2+-independent PLA (iPLA)
subfamily, particularly iPLAβ and iPLAδ could be involved in this process. (19, 50, 96 and 186).
5.1.3 Secretory PLAs (sPLA2s)
sPLA2s  represent  a  group  of  low  molecular  weight  enzymes  that  require  Ca2+ at  mM  concentrations  for  their
activity.  To  date,  11  mammalian  isoforms  of  sPLA2 have been identified (68, 163). In addition, other members
exist that have been isolated from different venoms (184, 225).
5.1.3.1 Structure and Properties
PLA2s belonging to the groups I, II, V and X are considered as conventional sPLA2s and are closely related (235,
278). They share a highly conserved catalytic domain (His-Asp dyad), a Ca 2+ -binding loop (XCGXGG) and 6-8
conserved disulfide bridges that contribute to a high degree of stability to the enzymes. On the other hand, PLAs
that belong to the groups III and XII are structurally different from those conventional sPLAs as deduced from
their protein sequences (58, 106, 238). The molecular weight of sPLA2s range from ~13 to 19 kD except for the
Group III isoform that has a mass of 55 kD. An aspect that is most common for all sPLA2s is that they share a ~15
Å deep active site slot that could fit a single GPL molecule positioned in such a way that the enzyme-suspectible
ester is next to the catalytic residues (90, 92, 138 and 139).
9Figure 2. Hypothetical model of GIA PLA2 (cobra venom PLA2) in association with a DMPC membrane surface.
(Adapted with permission from: Burke, J.E, et al, (2008), Biochemistry, 6451-6459)
Most  of  the  extracellular  sPLAs  require  high  Ca2+ concentrations (mM) to operate effectively on membrane-
bound GPLs, a phenomenon known as "interfacial activation" (92). It has been suggested that "interfacial
activation" could largely be a result of the specific conformation assumed by the substrate in an aggregated form
(240). Earlier studies have also shown that GPL substrate must be in an aggregated form (i.e; micellar or bilayer)
for optimal enzyme activity (190, 220). The transfer of a GPL molecule from an ordered interface to the active site
requires less energy than with monomeric substrates as their conformation is random. A recent study by Qin et al
demonstrated through modeling studies that in the presence of zwitter ionic membranes, sPLA2s favor the
hopping mechanism (223). Crystal structures of a few of these enzymes (members of Groups IB, IIA and X) have
been solved both with and without a bound transition state analogue or an inhibitor (71, 215, 238-240 and 248). It
is assumed that the catalytic mechanism for sPLA2 -catalyzed ester degradation is initiated by the His-Asp dyad in
a Ca2+ -dependent manner through the abstraction of a proton from an incoming water molecule followed by a
nucleophilic attack on the carbonyl-carbon at the sn-2 position of the GPL thereby leading to the rate-limiting
formation of a putative tetrahedral intermediate. Next, protonation of the sn-2 oxygen mediated through His48 in
concert with the productive collapse of the tetrahedral intermediate leads to the formation of a free fatty acid and a
lyso-GPL (184).
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It  has  been  established  that  mammalian  sPLA2s carry out important biological functions such as dietary GPL
digestion [IB] (231, 277), host defense against parasitic, bacterial and viral infections [IIA, V, X, XII] (163) and
eicosanoid mediated inflammation [X] (112). Several reports have speculated a role for various mammalian
sPLA2s in a wide range of diseases that include pancreatic acinarcarcinoma [IB] (47), arthritis, atherosclerosis,
sepsis, cancer [IIA and V] (36, 198, 233 and 272), chronic obstructive pulmonary disease [IID] (130) and asthma
[IID] (6). There is no evidence from any of the earlier studies that sPLA2s are involved in GPL homeostasis.
5.1.4 Ca2+-independent PLAs (iPLAs)
iPLAs  are  also  known  as  the  Group  VI  PLAs  or  patatin-like  PLAs  and  consist  of  seven  members,  that  include
iPLAβ [VIA-1 and -2] (PLA2GVIA, PLA2G6, PNPLA9), iPLA2γ (PLA2GVIB, PNPLA8), iPLA2δ (PLA2GVIC,
NTE, PNPLA6), iPLA2ε (PLA2GVID, Adiponutrin, PNPLA3), iPLA2ζ (PLA2GVIE, Desnutrin, ATGL, PNPLA2),
iPLA2η (PLA2GVIF, GS2). In addition, three more isoforms have been identified (iPLA2φ, iPLA2ι,  and iPLA2κ)
but then not much is known about them so they haven’t been assigned to this group yet (150, 157, 195, 197, 301
and 303). Members of this family carry out substrate hydrolysis through a catalytic dyad (Ser-Asp) and do not
require Ca2+ for  their  activity  (4,  19,  194).  No  crystal  structure  for  any  of  these  isoforms  is  available  at  the
moment. Interestingly, the isoforms: iPLAβ and iPLA2γ possess a long N-terminal domain which is speculated to
facilitate protein-protein interactions and membrane spanning. In addition, both these variants are true PLAs,
while the other members mainly hydrolyze triglycerides or act as transacylases (226).
5.1.4.1 Structure and Properties of iPLAβ
The Group VIA PLA gene yields at least 5 splice variants (VIA-1, VIA-2, VIA-3, VIA-Ankyrin1 and VIA-
Ankyrin2) of which the 85 kD (VIA-1) and 88 kD (VIA-2) forms are catalytically active and manifest PLA1/PLA2,
lyso-PLAs and transacylase activities (175, 182, 303 and 305). The full-length variant of iPLAβ protein is of 752
amino acids containing 7 ankyrin repeats, a 10-40 amino acid residue spacer linkage and a catalytic domain that
harbors the GTSTG stretch (267). Earlier studies suggest that the ankyrin repeats maybe crucial for protein-
protein interactions and it is suspected that the splice variant, GVIA-Ankyrin1 acts as a negative regulator of
iPLAβ by blocking the formation of active tetramers of iPLAβ (166). iPLAβ also contains other domains such as
an ATP binding consensus motif (GGGVKG) that allows its regulation by ATP, an N-terminal caspase-3 cleavage
site (DVTD), a putative bipartite nuclear localization sequence (KREFGEHTKMTDVKKPK) and a calmodulin-
binding stretch (AWSEMVGIQYFR) that helps it to form a signaling complex with CaMKIIβ (1, 41, 84, 109, 140,
175, 185, 274 and 303). The hydrolysis of GPL substrate proceeds through an acyl-enzyme intermediate (as in
sPLA2s) except that here serine acts as a nucleophile after aspartic acid has abstracted a proton from it (175, 194).
It has been observed that iPLAβ seems to mediate "interfacial catalysis" by acting in the scooting mode (194).
Deuterium exchange experiments in combination with molecular dynamic (MD) simulations revealed that five
different regions in iPLAβ facilitate its binding to the membrane, one of which (708-730 residues) is located in the
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catalytic domain and is involved in membrane penetration, while the remaining four interact with the charged
head group of which one region (378-389 residues) is located in the ankyrin region and the rest (631-655, 658-664
and 773-778 residues) in the catalytic domain (127).
Figure 3. A  system  of  iPLAβ and  a  PAPC  molecule  embedded  in  a  POPC  membrane  that’s  used  for  steered
molecular dynamics simulations. (Adapted with permission from: Mouchilis, DV, et al. (2014), PNAS, E516-525)
The first proposed role for iPLAβ was that of in GPL remodeling (20). Other studies employing iPLAβ-deficient
mice suggest that the enzyme is involved in a number of major cellular events such as apopotosis (13), cell
proliferation (262), insulin secretion (23), bone formation (227) and sperm development (24). In addition, iPLAβ
has also been implicated in a large number of diseases that include various neurological disorders such as infantile
neuroaxonal dystrophy (INAD), multiple sclerosis, alzheimers and also hypertensive heart failure (5, 28).
5.1.5 Cytosolic PLAs (cPLAs)
The cPLA family constitute six paralogs (PLA2 GIVA, B, C, D, E and F) which are also referred to as cPLA2 α, β,
γ, δ, ε, ζ respectively and they all share the lipase consensus sequence GXSGS (11, 152, 211, 218, 252 and 275).
The C2 domain that facilitates membrane binding is also conserved in all the members except in cPLA2γ which is
unique in that it exhibits Ca2+ -independent PLA2 activity (11).
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5.1.5.1 Structure and Properties of cPLA2α
The cPLA2α enzyme is ubiquitously expressed and contains 749 amino acids and has a molecular weight of 85.2
kD (52, 158). cPLA2α was first identified in human platelets in 1986 (154), and was later cloned and sequenced in
1991 (51, 155). It is the only member of the cPLA family that exhibits selectivity for AA (51, 93). In addition, it
also possesses PLA1, lyso-PLA as well as transacylase activities (230). The X-ray crystal structure of cPLA2α has
been resolved (69). The crystal structure shows that cPLA2α consists of two major domains i.e, (i) an N-terminal
Ca2+ -dependent C2 domain (CaLB) that was found to be essential for the initial association of the enzyme with a
membrane (95, 154, 249) in response to increasing intracellular Ca2+, that in turn induces phosphorylation of
certain serine residues, (ii) a catalytic domain that is composed of a hydrolase core and a novel cap region within
which a lid exists, that has to move aside for a GPL molecule to enter the active site cavity of cPLA2α (42, 194).
cPLA2α utilizes  a  similar  catalytic  mechanism as in  iPLAβ as  they share the same catalytic  active site  residues
(Ser/Asp)  (17,  170).  In  addition  to  Ca2+, activation of cPLA2α has also been shown to be regulated through
phosphorylation on its multiple serine residues (505, 515, 727) by MAPKs and Ca 2+/calmodulin-dependent
protein kinase II (119, 169, 174 and 224). Other studies have shown lipid messengers: ceramide-1-phosphate and
phosphatidylinositol (4,5) bisphosphate to play a role in enzyme activation upon binding to it (254).
Figure 4. Ribbon diagram of cPLA2 α. The C2 domain is  shown in green and the Ca2+ atoms in red.  The “cap”
region is  in  purple  while  the flexible  linker  between the C2 and catalytic  domains is  colored red.  (Adapted with
permission from: Dessen, A, et al. (1999), Cell, 349-360)
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Several studies have established that cPLA2α plays a central role in triggering AA release and eicosanoid
production (2, 37, 41, 152 and 276). Using cPLA2α knockout mice to generate disease models, it has been shown
that the enzyme is involved in a number of physiological and pathological diseases such as arthritis (1999),
inflammmatory bone resorption (193), pulmonary fibrosis (200) acute respiratory distress syndrome (200, 201),
autoimmune encephalomyelitis (187) and diabetes (214).
5.1.6 Factors determining substrate specificity of soluble PLAs
An accepted model of the catalytic cycle of soluble PLAs takes places in 4 steps (69, 239, 241 and 268):
1.) Binding of the enzyme to the membrane surface through its interfacial binding region,
2.) Upward movement (efflux) of the GPL molecule from the macrosubstrate,
3.) Accommodation of the substrate in the catalytic active site,
4.) Cleavage of the acyl-glycerol ester bond, with subsequent release of products.
Figure 5. Representation of the accepted model of the catalytic cycle of soluble PLAs  (1) Enzyme-membrane
association [E-M], (2) Efflux of the substrate from the membrane [E-M*], (3) Accommodation of substrate in the
catalytic site [ES-M], (4) Hydrolysis of the bound substrate with release of products [EP-M].
Among these, only steps 2 and 3 determine the substrate specificity of the enzyme. (See below)
5.1.6.1 Substrate accommodation at the catalytic site
Previous studies  have demonstrated that  interaction of  the GPL acyl  chains with the active site  cavity is  critical
especially in micelles (65, 171). Significant differences were observed between associations of sn-1 vs. sn-2 acyl
chains with various PLAs (219). White et al. found that when a truncated version of a nonhydrolyzable PC in a
micellar macrosubstrate was presented to cobra sPLA2, a tighter interaction with the sn-2 acyl chain vs. the sn-1
one was observed (300). Further, Yu and Dennis showed that cobra sPLA2 favors GPL analogues constituting
truncated acyl chains with a steady increase when the length of the sn-2 chain reached 9 carbons after which there
was an abrupt drop (310). Similar results were obtained by Roberts and colleagues who showed that when the
chain length was varied in the sn-2 chain, the variant with 8 carbons was the best substrate for cobra sPLA2 (232).
All these results suggest that accommodation at the active site determines the rate of hydrolysis in micelles.
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5.1.6.2 Substrate efflux from the lipid bilayer
Importance of an upward movement of the substrate molecule (efflux) from a membrane bilayer to the active site
has been studied using cross-linkable and polymerized GPLs (250, 308). That substrate efflux, is necessary for a
GPL  substrate  to  be  hydrolyzed  by  a  PLA  is  based  on  the  assumption  that  soluble  PLAs  may  not  be  able  to
penetrate the membrane significantly and therefore the catalytic site remains well above the interface (90, 175). In
addition, recent studies employing hydrogen/deuterium exchange and MD simulations have proposed that the
substrate molecule has to be extracted (i.e. efflux) from the membrane in order for it to reach the active site for its
hydrolysis (40, 126, 127). These findings strongly suggest that efflux propensity could be rate-limiting in the
hydrolysis of GPL substrate by PLAs in vesicle bilayers.
5.1.7.1 Superlattice model
As mentioned earlier, GPL synthesis and degradation are processes that must be closely controlled and strictly
coordinated in order to maintain membrane lipid homeostasis. However the mechanisms underlying these
processes remain largely obscure. Previous studies (63) have indicated that there is a strong possibility that the
biophysical properties of the bilayer could regulate these processes. One of the models that has been proposed
with such a possibility is the superlattice model which proposes that amphipathic lipids have a tendency to adopt
regular, superlattice distributions rather than random lateral distributions in multicomponent bilayers (251). This
model  is  relevant  in  the  context  of  regulation  of  membrane  GPL  homeostasis  for  two  reasons.  First  the  model
predicts the existence of a limited number of "critical" or allowed GPL bilayer compositions that are energetically
more favorable (membrane free energy at a local minimum) than the intervening ones and therefore there is an
intrinsic tendency for the composition to settle in one of the critical compositions. A simple mechanism as this,
would minimize wasteful compositional fluctuations. Second, whenever the concentration of a GPL exceeds a
critical value in a bilayer, packing defects appear as the molecules "in excess" could not be accommodated in an
arrangement predicted by the superlattice model. Thus molecules "in excess" would consequently form segregated
domains where they are more loosely packed. Those loosely packed molecules are predicted to have an increased
chemical activity and therefore increased fugacity (escape tendency) which would thus make them susceptible to
hydrolysis  by homeostatic  PLAs.  Once the GPLs "in excess"  are  hydrolyzed,  the loosely packed domains at  the
lattice boundaries disappear, thereby greatly reducing the availability of GPLs to the homeostatic PLAs. Thus the
superlattice formation would provide a highly accurate mechanism for the regulation of membrane lipid
compositions. Supporting this model of regulation has been reported in which the hydrolysis of PC in
PC/Cholesterol bilayers by venom sPLA2 was more efficient at intervening compositions than in the allowed ones
(129).
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5.2 Mass-spectrometric analysis of lipids
Lipid compositions of mammalian cells are enormously complex and thus nearly impossible to resolve with
analytical techniques such as thin layer chromatography (TLC), however recent advances in mass spectrometry
(MS) lipidomics has greatly extended the analytical capabilities both in terms of sensitivity and selectivity thus
facilitating accurate identification and quantification of a multitude of lipid species simultaneously (103, 104,
105). Present lipidomic analyses rely on soft ionization techniques such as electrospray ionization (ESI) and
matrix-assisted laser desorption ionization (MALDI) (176). Analysis of lipids by ESI is based on the ability of
lipids to acquire a positive or negative charge when in solution. ESI has been preferred over other ionization
techniques such as MALDI (87, 97) and atmospheric pressure ionization for lipid analysis (44, 132). Separation of
ions is obtained by various analyzers, such as the ion trap or a multiple quadrupole. ESI-MS is carried out either
by direct infusion of the sample into the mass-spectrometer or by combining the MS with a liquid
chromatography equipment (LC).
5.2.1 Direct infusion and class specific scanning
Direct infusion (DI) method is also known as shotgun lipidomics method (34, 153). Shotgun lipidomics was
coined  for  the  first  time  by  Han  & Gross  in  1994  and  can  evade  a  number  of  difficulties  that  could  arise  from
chromatographic problems, such as non-specific absorption (104). In addition, the shotgun approach in
combination with class specific fragmentation strategies can detect most GPLs with high sensitivity and
specificity as they are readily ionized by either protonation to form (M+H)+ or deprotonation to form (M-H).
Precursor-ion scanning (PIS) is achieved by first introducing the ions formed in the ion source into the first
quadrupole analyzer (Q1), which is scanned over a wide mass range corresponding to various GPLs. The
molecules passing through Q1 are subjected to collision-induced dissociation (CID) in the 2nd quadrupole (Q2) or
in  the  collision  cell.  Finally,  Q3  transmits  the  mass  of  the  selected  fragment.  Profiling  of  GPLs  by  neutral  loss
scanning (NLS) is used to detect PS and PE. In a neutral loss scan, Q1 and Q3 analyzers scan the same mass range,
except that in Q3 the mass range is lowered by the mass of a neutral fragment e.g. 87 Da to detect the loss of the
phosphoserine group from PS. It should be noted that the mass accuracy of the mass spectrometer (MS) during
NL scanning mainly depends on the mass difference between Q1 and Q3 analyzers and also the mass accuracy of
these two analyzers. This method has its own disadvantages primarily that isobaric species cannot be quantified
unless subjected to fragmentation. Further, quantification of molecular species that have low level concentrations
could be a difficult task to perform (107).
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5.2.2 Liquid chromatography-mass spectrometry (LC-MS)
In order to obtain maximum sensitivity of detection for lipid species that are low in abundance, selected reaction
monitoring  (SRM)  in  a  triple  quadrupole  instrument  is  often  carried  out  (98).  Normal  phase  LC  column  is
employed to separate individual lipid classes and a reverse-phase column is used to resolve molecular species in a
lipid class based on the different hydrophobicities of different acyl chain residues of GPLs. LC-MS is often more
sensitive than DI-MS because it allows separation of signal by suppressing impurities and competing analytes.
But  then  there  are  also  a  number  of  difficulties  that  could  limit  usage  of  LC-MS while  carrying  out  large  scale
analysis of lipids primarily due to the mobile phase compositions that can introduce errors in ionization efficiency
(99, 192, 151). Major drawbacks include an increase in analysis time, cost of analyzing and in addition, loss of
lipids on the column which is not an unusual event (66).
5.2.3 Data Analysis
MS analysis of lipids generates vast amounts of data, processing of which requires proper software tools.
Accordingly, a number of software packages have been developed that carry out multiple data-processing tasks
such as spectral filtering, peak detection, normalization and quantification (75, 85, 108, 116 and 135). In our
laboratory, a software termed LIMSA was developed for DI-MS data analysis. It is an add-in program that runs on
EXCEL, it serves as an interface to process data from individual full MS and tandem MS spectra (100). For LC-
MS data as well, programs have been developed that take into consideration both the elution times and the
determined mass of individual molecular species (74, 117, 146, 221 and 237).
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6. AIMS OF THE PRESENT STUDY
The main objective of the present study was to elucidate the factors regulating the substrate specificities of A-type
phospholipases (PLAs) by using high-throughput mass spectrometry as a key tool. Specific aims for individual
publications were as follows:
1. To develop a mass-spectrometric method to determine the key factors that regulate the substrate
specificity of nonhomeostatic PLAs. (A proof of principle study)
2. To  study  if  substrate  efflux  propensity  regulates  the  activity  of  iPLAβ,  a  putative  player  in  GPL
homeostasis.
3. To  study  the  key  factors  that  regulate  the  substrate  specificity  of  cPLA2α,  which  has  a  crucial  role  in
liberating arachidonic acid, a precursor of eicosanoids from GPLs.
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7. EXPERIMENTAL PROCEDURES
7.1 List of the experimental methods used in this thesis work (Table 1)
Experimental protocol Study
Cell culture (II, III)
Cloning and over-expression of PLAs (II, III)
Purification of PLAs by affinity and ion-exchange chromatography (II, III)
Protein concentration determination (177, 259) (II, III)
Immunoblotting (162) (II, III)
Synthesis of GPL classes (216) (I, II, III)
Purification of GPL classes by HPLC (I, II, III)
Determination of GPL concentration by phosphate assay (26) (I, II, III)
Radioactivity assay of PLAs (II, III)
Assay of PLA specificity with micelles or vesicle bilayers (101) (I, II, III)
Lipid extraction (83) (I, II, III)
Separation of various lipid classes by TLC (I, I, II)
Mass spectrometry and Data analysis (100, 116) (I, II, III)
Spontaneous intervesicle transfer assay (143) (I, II)
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7.2 PLA activity assay
A mixture of synthetic GPLs, 16:0/18:1-PA and 21:00-SM (internal standard) were mixed in chloroform, dried
under a N2 stream and further under high vacuum for 1 h. To prepare small unilamellar vesicles (SUVs), the dried
lipids were dissolved in 20 µL ethanol and injected into 0.5 mL of the assay buffer (20 mM Tris-HCl, pH 7.5, 5%
glycerol) using a constant-speed Hamilton syringe. The SUV bilayers were then incubated in the presence of the
purified PLA at  37 °C,  50 µL aliquots  were removed at  intervals  and mixed with 2 mL of  ice-cold methanol  to
stop the reaction. After addition of 0.8 mL water and 4 mL chloroform, vortexing and removal of the upper phase,
the lower phase was washed twice with the theoretical upper phase and taken to dryness under a N2 stream (83).
The residue was reconstituted in 200 µL of chloroform/methanol (1:2, v/v) and stored at -20 °C. To prepare large
unilamellar vesicles (LUVs), lipids were dried in a glass tube, overlaid with 1 mL of the assay buffer and placed
in  a  water  bath  at  4  °C  for  1  min  and  then  in  a  water  bath  at  50  °C  for  1  min.  This  cooling-heating  cycle  was
repeated for 4 times. The lipid suspension was vortexed for 1 min at room temperature then extruded 10 times
through two stacked 1.2 µm polycarbonate membranes and then 10 times through two 0.4 µm membranes using
an extruder pressurized with Argon. To study the hydrolysis in micelles, a dried lipid mixture was first dispersed
in the assay buffer containing 1% Triton X-100 and the assay was conducted as above.
7.3 Mass-spectrometry and Data Analysis
After addition of 25% NH4OH in water (4% final concentration) the sample was infused to a Micromass Quattro
Micro triple-quadrupole mass spectrometer (116). The GPL species were detected using head group-specific
precursor or neutral-loss scanning (111). The spectra were exported to Microsoft Excel and the individual GPL
species were quantified using the LIMSA software (100). Concentrations of the individual lipid species were
plotted against time and the relative rate constants of hydrolysis were obtained by fitting a first order decay model
to the data. The maximum hydrolysable fraction at t∞ was constrained to 1.0 with micelles and to 0.67 with SUVs
(101).  LC-MS  with  selective  reaction  monitoring  (SRM)  was  carried  out  using  a  Waters  ACQUITY  Ultra
Performance  LC  system  equipped  with  a  Waters  ACQUITY  BEH  C18 column (1.0 × 100 mm) to separate the
molecular  species  using  gradient  elution.  The  eluent  was  directed  to  the  ESI  source  of  Waters  Quattro  Premier
triple-quadrupole mass spectrometer operated in the positive ion mode. The SRM chromatograms were integrated
and the relative concentrations of the individual GPL species were calculated using the QuanLynx software (27).
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8. RESULTS AND DISCUSSION
8.1 The factors that regulate the substrate specificities of sPLA2s determined by a novel mass-spectrometric
assay.
Traditionally,  evaluation  of  the  specificity  of  PLA2s  was  done  by  measuring  the  rate  of  hydrolysis  of  a  few
radiolabeled substrates individually. Such an approach is tedious if multiple species are to be studied. In addition,
variations in enzyme activity could arise from physical properties of the substrate determined by the lipid under
study, such as membrane surface charge and fluidity. To improve this, specificity could be studied by comparing
the  hydrolysis  of  two  GPLs  that  have  different  isotope  labels  (92),  but  even  this  approach  is  tedious  when
studying multiple GPL species (70). In this case a mass-spectrometric approach is much more convenient as it
allows one to study a multitude of GPLs simultaneously. Here a high-throughput mass-spectrometric assay was
developed to determine the effect of acyl chain length and unsaturation of GPLs on the rate of hydrolysis by three
different sPLA2s in micelles and vesicle bilayers.
Three different mixtures of synthetic GPL species were used. The first mixture (“PC-mix”) consisted of a total of
27 species  i.e.,  (i)  10 disaturated species  with the length of  both acyl  chains varying from 13 to 22 carbons;  (ii)
three monounsaturated species (14:0/18:1 and 16:0/18:1); (iii) 6 species with two double bonds, including
16:0/18:2 and 5 dimonounsaturated species with acyl chain lengths varying between 14 to 22 carbons (14:1/14:1,
16:1/16:1, 18:1/18:1, 20:1/20:1 and 22:1/22:1); (iv) three species with four double bonds (16:0/20:4 and
18:0/20:4); (v) three species with 6 double bonds (18:3/18:3, 16:0/22:6 and 18:0/22:6); (vi) one with eight double
bonds (20:4/20:4); and (vii) one with 12 double bonds (22:6/22:6). The second mixture (Cn/16:0-PCs) consisted of
18 saturated PC species with a 16:0 sn-1  chain  and  a sn-2 chain of 6-24 carbons, and the third mixture (D9-
16:0/Cn-PCs) consisted of the positional isomers of the second one. Each mixture also contained, 21:0-SM, a non-
hydrolyzable internal standard and 5 mol% of POPA (for it gives a negative charge to the macrosubstrate that
helps increase the affinity of the enzyme). The lipid mixtures were presented to the enzyme either in the form of
vesicle bilayers or detergent micelles.
8.1.1 Effect of the acyl chain length and unsaturation (“PC-mix”)
8.1.1.1 Micelles
Each of these enzymes showed different specificities with micelles, small unilamellar vesicles (SUVs) and large
unilamellar vesciles (LUVs). SUVs measure between 20 and 100 nm in size and LUVs between 100 and 400 nm.
With bee sPLA2, a decrease in hydrolysis rate took place with increasing acyl chain length both with saturated and
diunsaturated PC sets. Similarly, hydrolysis by cobra sPLA2 modestly decreased with increasing acyl chain length.
In the case of porcine sPLA2, this occurred mainly with the diunsaturated species. On the other hand, increase in
the number of double bonds in the acyl chain led to an increase in the rate of hydrolysis by the bee sPLA2 (Fig 5,
left panel). A notable observation was that the PC species containing AA were hydrolyzed more rapidly than the
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other PC sets. With cobra sPLA2, substrate unsaturation did not have any effect on the hydrolysis rate except for
those that contained 18:3 and 22:6 fatty acids. Again with porcine sPLA2, substrate unsaturation had a major
effect on the short di-unsaturated species and also on species containing 16:0/18:2 and 18:3/18:3 fatty acids.
8.1.1.2 Vesicle bilayers
The  specificity  profiles  obtained  with  these  three  enzymes  in  SUV  bilayers  were  very  different  from  that  in
micelles. First with bee sPLA2, there was a clear difference in the rate of hydrolysis that was far more pronounced
than it was in micelles (Fig 5, right panel). For instance, the difference between the most slowly hydrolyzed and
the most rapidly hydrolyzed species was ~100 fold vs. 10-fold in micelles. Substrate unsaturation seemed to have
an effect on the rate of hydrolysis but then again AA containing species were hydrolyzed much faster as was
observed in micelles.  Analogous results  were obtained with LUVs.  As with cobra sPLA2, the length of the acyl
chain had a much stronger effect on the rate of hydrolysis with the saturated and diunsaturated PC sets than that in
micelles.  A  similar  trend  was  observed  with  LUVs.  Also  with  porcine  sPLA2, the inhibitory effect of the
increasing acyl chain length was much stronger in SUVs than in micelles. Collectively, these data indicate that the
acyl binding sites for each of these PLAs differ from one another quite significantly, which is in agreement with
crystal structure data (71, 215, 238, 239 and 248).
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FIGURE 6. Hydrolysis of saturated and unsaturated PC species by bee, cobra or porcine sPLA2s in
octylglucoside micelles (Left panel) and SUVs (Right panel). Relative rates of hydrolysis are plotted against the
total number of acyl chain carbons for several sets of PC species containing a fixed number of acyl chain double
bonds.
23
8.1.2 Effect of sn-1 vs. sn-2 chain length
To get more information on the contribution of the individual acyl chains on the rate of hydrolysis, two different
sets  of  saturated PC species,  one containing a  D9 labeled head group and the other one unlabeled were studied.
The length of either the sn-1 (Cn/16:0-PCs) or the sn-2 (D9-16:0/Cn-PCs) acyl chain varied from 6 to 24 carbons,
while the length of the acyl chain at the other sn position was constant at 16 carbons. Since the 16:0/Cn-PC species
contained  a  D9-labeled choline head group while the Cn/16:0-PC species were unlabeled, both sets could be
present together thus eliminating the possibility of any matrix bias. Experiments with these positional isomers
presented in micelles showed significant differences in the hydrolysis rates, i.e. the rate of hydrolysis decreased
monotonously with the length of the sn-1 chain, while for sn-2 chain an optimum at C8 - C10 was observed for
each of the 3 enzymes (Fig 6, left panel). These data suggest that those enzymes contain a binding site for the sn-2
chain, but not for the sn-1 chain thus allowing the sn-2 chain to interact more tightly. This conclusion is consistent
with both crystallographic and NMR data from studies obtained from cobra sPLA2 complexed with substrate
analogues (219, 300). In contrast to micelles, an identical effect was observed when the length of the sn-1 vs. sn-2
chain was varied in vesicle bilayers (Fig 6, right panel). There was no significant discrimination between the
positional isomers, suggesting that translocation of the GPL substrate from the bilayer to the active site mainly
determines the rate of hydrolysis of membrane-bound GPLs. This conclusion is in agreement with previous data
on hydrolysis of cross-linkable or polymerizable lipids by venom sPLA2 (250, 308).
The key finding of this study is that efflux propensity seems to be a much more important factor in the hydrolysis
of membrane-bound GPL molecules by sPLA2s than previously thought. Accommodation of the GPL acyl chains
at the substrate binding site of the enzyme also seems to contribute to the specificity of the sPLA2s studied here,
as indicated by the data obtained with micelles.
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FIGURE 7. Hydrolysis of D9-16:0/Cn-PCs  and  Cn/16:0-PCs in octylglucoside micelles (Left panel) and SUV
bilayers (Right panel) by bee, cobra or porcine sPLA2s. The relative rate of hydrolysis is plotted against the
number of acyl chain carbons in the variable chain for both isomeric sets.
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8.2 Substrate specificity of iPLAβ, a putatively involved player in GPL homeostasis
The high-throughput mass-spectrometric assay developed in the first study was implemented here to determine if
efflux of the substrate molecule from the bilayer is the rate-limiting step in GPL hydrolysis by iPLAβ like in the
case of sPLA2s (see above). A mixture of six 18:1/18:1 GPLs each with a different head group was also included
in this study.
8.2.1 Effect of acyl chain length and unsaturation (“PC-mix”)
8.2.1.1 Micelles
We first studied the relative rates of hydrolysis of PC species with varying acyl chain length and unsaturation.
With micelles as the macrosubstrate, the rate of hydrolysis decreased with increasing chain length which was
observed  across  all  the  different  PC  series  and  an  increase  in  acyl  chain  unsaturation  increased  the  rate  of
hydrolysis markedly (Fig 7, left panel). In particular, the effect of an increase in unsaturation can be noticed in
species with a total of 36, 38 or 40 acyl chain carbons that are hydrolyzed at a faster rate than their saturated
counterparts.  The  cause  for  this  could  be  in  part  due  to  specific  interactions  of  such  species  with  the  substrate
binding site on the enzyme.
8.2.1.2 Vesicle bilayers
As observed with micelles, an increasing acyl chain length led to a decrease in the rate of hydrolysis with vesicles.
The effect of chain length was however more pronounced with vesicle bilayers (Fig 7, right panel). With the
saturated series, the difference between the slowest and the fastest species was ~50-fold in bilayers while it was
only ~7-fold in micelles. Increasing number of double bonds increased the rate in hydrolysis when the chain
length was constant. These data strongly support the idea that acyl chain hydrophobicity is a key factor in iPLAβ-
mediated GPL hydrolysis.
The differences between micelles and vesicle bilayers probably derive from different packing i.e. intermolecular
interactions in these two macrosubstrates. MD simulations (183) and NMR studies (299) have demonstrated that
the intermolecular packing in micelles is looser than in bilayers. In addition the efflux of the substrate molecule
from micelles is several fold faster as compared to vesicle bilayers (205). These data support the idea that
substrate efflux is the key determinant in the hydrolysis of membrane-bound PC species by iPLAβ.
26
Figure 8. Hydrolysis of saturated and unsaturated PC species by iPLAβ in TX-100 micelles (Left panel) and SUVs
(Right panel). Relative rates  of  hydrolysis  are plotted against the total number of acyl chain carbons for several
sets of PC species containing a fixed number of acyl chain double bonds.
8.2.2. Effect of sn-1 vs. sn-2 chain length
8.2.2.1 Micelles
To study how the variation of the length of the sn-1 or sn-2 chains independently affect the rate of hydrolysis, both
the  isomer  sets,  D9-16:0/Cn-PCs and Cn/16:0-PCs were incubated with iPLAβ. With micelles as the
macrosubstrate, an increase in the length of the sn-1  chain,  did  not  have  any  effect  on  the  rate  of  hydrolysis  at
least until C12 and then a decrease in a logarithmic manner was observed (Fig 8, left panel). On the other hand
increasing the sn-2 chain led to an increase in the hydrolysis rate first from C7-C8 and then declined in a rather
monotonous manner. The ratio between the slowest and the fastest hydrolyzed species was ~14.5 and ~23.7 for
the D9-16:0/Cn-PC and Cn/16:0-PC series respectively. It could be possible that the differences observed between
the two sets of positional isomers might be due to the different properties of the sn-1 vs. sn-2 acyl binding sites of
iPLAβ. Therefore, unlike the sPLA2s, iPLAβ hydolyzes both the acyl chains as has been suggested in previous
works (1, 305).
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8.2.2.2. Vesicle bilayers
With vesicles bilayers, while increasing the length of acyl chain in either sn-1 or the sn-2 position caused a
dramatic decrease in the rate of hydrolysis (Fig. 8, right panel), no significant differences in hydrolysis were
observed for either positional isomer. Such strong and monotonous decrease of hydrolysis further supports the
notion that efflux of the GPL substrate from the bilayer is the rate-limiting step in the hydrolysis of membrane-
bound substrates by iPLAβ. The fact that there were no significant differences observed between the positional
isomers agrees with recent hydrogen/deuterium and homology modeling studies suggesting that efflux of the
substrate from the membrane is necessary for its hydrolysis by iPLAβ (126, 127).
FIGURE 9. Hydrolysis of D9-16:0/Cn-PCs and Cn/16:0-PCs in TX-100 micelles (Left panel) and SUV bilayers
(Right panel) by iPLAβ. Relative rates of hydrolysis are plotted against the number of acyl chain carbons in the
variable chain for both isomeric sets.
8.2.3 Effect of GPL polar head group structure
In order to determine the effect of the polar head on the rate of hydrolysis, a mixture constituting six 18:1/18:1
GPLs  each  with  a  different  polar  head  group  was  presented  to  iPLAβ in  SUV,  LUV  or  micelle  matrices.  With
micelles, clear differences in hydrolysis were observed between the different GPLs (Fig 9). These differences
probably  reflect  the  structural  properties  of  the  active  site  of  iPLAβ.  In  contrast,  all  the  GPL  species  were
hydrolyzed at similar rates in bilayers. To assess the accuracy of the effect of the head group, spontaneous
intermembrane translocation assay was carried out as it is the best way to measure those effects. In this assay, the
rate of transfer was determined by monitoring the movement of a lipid from two vesicle populations, from
charged donor to neutral acceptor vesicles (143).
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FIGURE 10. Hydrolysis of 18:1/18:1 PC, PE, PS, PI, PG and PA by iPLAβ in micelles, SUV and LUV bilayers.
The data is normalized to that of the most rapidly hydrolyzed GPL in each system.
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8.3 Substrate specificity of cPLA2α, an enzyme releasing AA from GPLs.
A number of studies have demonstrated that cPLA2α has selectivity toward arachidonoyl containing GPLs (41,
156).  Here  we  studied  to  which  degree  this  specificity  is  determined  by  accommodation  vs.  efflux.  For  this  we
included in this study also 20:4 containing molecular species GPL in two isomeric PC sets (Cn/20:4-PCs; n=6-24)
and (20:4/Cn-PC; n=6-24).
8.3.1 Effect of the acyl chain length and unsaturation (“PC-mix”)
8.3.1.1 Micelles
In micelles, the unsaturation of the acyl chains of PC had very little effect on the rate of hydrolysis except when
one or two 20:4 containing acyl chains were present (Fig 10A). The slightly faster hydrolysis of PCs containing
two vs. one arachidonoyl chain may be due to faster efflux of the former species. This may also be the reason for
the faster hydrolysis of the di-18:3 and di-22:6 species vs. the more saturated species with the same number of
acyl chain carbons. Increasing the acyl chain length had no effect on the rate of hydrolysis except when the acyl
chain  was  very  long  (Cn=44).  Collectively,  these  data  indicate  that  accommodation  at  the  active  site  is  more
important than efflux for hydrolysis by cPLA2α in micelles which is as expected. Results also indicate that the
active site can accommodate two AA chains simultaneously.
8.3.1.2 Vesicle bilayers
In vesicle bilayers the rate of hydrolysis for species with 20:4 at the sn-2 position was slower (6-fold difference
between micelles and vesicles) indicating that efflux is a more important determinant in vesicles (Fig 10B). Di-
20:4 was hydrolyzed relatively much faster (than GPLs containing AA only at the sn-2 position) in vesicles vs.
micelles suggesting that efflux is a relatively more important factor in the former case. Data from this experiment
are in contrast to our earlier data from sPLA2s and iPLAβ with which a stronger inhibitory effect with increasing
hydrophobicity was observed (27, 101). This could probably be due to the reason that cPLA2α penetrates more
significantly into the bilayer in which case the substrate doesn’t need to efflux much in order to reach the active
site which might not be the case with the other PLAs.
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FIGURE 11. Hydrolysis of saturated and unsaturated PC species by cPLA2α in TX-100 micelles (Top panel) and
SUVs (Bottom panel). Relative rates  of  hydrolysis  are plotted against the total number of acyl chain carbons for
several sets of PC species containing a fixed number of acyl chain double bonds.
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8.3.2 Effect of sn-1 vs. sn-2 chain length
Micelles
When no AA was present in a PC, no significant isomer preference was observed in micelles. Increasing the
length of the saturated acyl chain in either position had hardly any effect on the rate of hydrolysis by cPLA 2α until
C17, beyond which a rapid decrease in hydrolysis rate occurred thus suggesting that both the sn-1 and sn-2 acyl
chains share a similar binding cavity equalling a length of a C17 acyl chain. This is similar to the result observed
for iPLAβ (27) except that there the hydrolysis decreased rapidly already beyond C12 (Fig 11A, left panel), thus
indicating a shorter acyl binding site in that PLA. The results from the 20:4 containing PC isomer sets were
remarkably  different  (Fig  11B,  left  panel).  The  species  with  20:4  in  the sn-2 position of PC were hydrolyzed
approx. 4-fold faster than their positional isomers with 20:4 in the sn-1 position independent of the length of the
acyl chain indicating regiospecificity while with the saturated positional isomers there seems to be “sloppy”
binding i.e.; both the chains can occupy the same binding domain. These findings are consistent with previous
data indicating that cPLA2α prefers sn-1-saturated/sn-2-20:4 species in a regiospecific manner while binding of
disaturated PCs is promiscuous (95, 173, 194 and 228). Hydrolysis dropped significantly when the sn-1 chain was
longer that C16-C17, which may correspond to the length of the acyl binding site on the enzyme. All these data
suggest that accommodation at the active site is the key determinant of hydrolysis of GPL substrate by cPLA2α in
micelles.
Vesicle bilayers
With the saturated PC sets, hydrolysis decreased strongly and monotonously in an identical fashion with the
length of either acyl chain length except for one PC with a short C6 at the sn-1 position that deviated from this
trend (Fig. 11A, right panel). These data are similar to those observed for the other PLAs studied and suggest that
efflux of the GPL substrate is the key factor determining the rate of hydrolysis in vesicle bilayers. The rate of
hydrolysis in the PC isomer set containing 20:4 also diminished with increasing chain length, underlining the fact
that  efflux is  an important  factor  in  the hydrolysis  of  those species  as  well  (Fig 11B, right  panel).  However,  the
species with 20:4 in the sn-2 position were hydrolyzed much faster than their positional isomers (approx. 2 to 4
fold difference) indicating that, in addition to efflux there is more regiospecific orientation of the acyl chain
probably allowing the AA double bonds have favorable interactions with certain aromatic residues in the binding
pocket of cPLA2α (194).
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FIGURE 12. Hydrolysis of D9-16:0/Cn-PCs and Cn/16:0-PCs (left, upper panel) and 20:4/Cn-PCs  + Cn/20:4-
PCs (left, lower panel) in TX-100 micelles by cPLA2α. Hydrolysis of D9-16:0/Cn-PCs and Cn/16:0-PCs (right,
upper panel) and 20:4/Cn-PCs + Cn/20:4-PCs (right, lower panel) in SUV bilayers by cPLA2α. Relative rates of
hydrolysis are plotted against the number of acyl chain carbons in the variable chain for both isomeric sets.
8.3.3 Effect of GPL polar head group structure
Micelles
The rate of hydrolysis of six different 16:0/20:4 GPLs (PC, PE, PS, PI, PG and PI) by cPLA2α was compared in
micelles. The fastest hydrolyzed GPL was PA while the remaining GPLs were hydrolyzed at much lower and
almost comparable rates (Fig. 12A). Very similar data was obtained for the 18:1/8:1 derivatives. The reason could
be that PA has a smaller head group than the ones in the other GPLs which helps in binding the GPL substrate to
the active site. An earlier study indicated that cPLA2α has significant preference (approx. 4-7 fold) for PG over PE
and PC (PA and PI were not present) in Triton X-100 micelles (173, 304) which is consistent with the present data.
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Vesicles
Also  in  vesicle  bilayers,  PA  was  the  most  rapidly  hydrolyzed  GPL  but  then  PG  and  PC  were  hydrolyzed
significantly faster  than the remaining three GPLs that  had similar  rates  of  hydrolysis  (Fig 12B).  These smaller
differences between some GPLs in vesicles vs. micelles suggest that efflux propensity may be a more important
determinant of hydrolysis of GPLs by cPLA2α in vesicle bilayers. Efflux rate depends on the head group as
indicated by our studies on spontaneous transfer rate (Study II). All these data indicate that the contribution of the
head group is largely independent of the acyl chain composition.
FIGURE 13. Hydrolysis of 16:0/20:4 or 18:1/18:1 molecular species from different GPL classes by cPLA2α in
micelles (left/upper and lower panels) and SUVs (right/upper and lower panels). Data normalized to that of the
most rapidly hydrolyzed GPL in each system.
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8.3.4. Biological and clinical relevance
The present study provides novel information on factors determining the substrate specificity of PLAs that belong
to different sub-families. Prior to these studies, the relative contributions of the PLA active site structure and
substrate efflux propensity on GPL hydrolysis were poorly understood. Such information is necessary to fully
understand the mode of action of various PLAs as well as to establish why PLAs preferentially hydrolyze certain
GPL species. The secretory PLAs (sPLA2s) studied here are most probably involved in penetration of toxins to an
animal body. While the biological implications of the substrate specificities of the sPLA2 studied here are not
obvious, the rapid hydrolysis of 20:4 or 22:6-containing PC species by bee and snake sPLAs, respectively, might
contribute to the toxicity of the venom by increasing the production of bioactive metabolites derived of the 20:4 or
20:6 fatty acids.
iPLAβ are  involved  in  a  number  of  cellular  processes  particularly  in  GPL  homeostasis  which  depends  on  the
coordination of GPL synthesis and degradation by a yet unknown mechanism. The present data indicate that
efflux of the substrate from a membrane is critical for GPL hydrolysis by iPLAβ, which is intriguing considering
that efflux propensity, has been predicted to depend critically on the ratio of different lipids. Thus the present data
support the involvement of iPLAβ in GPL degradation (homeostasis) in mammalian cells. iPLAβ is also involved
in several metabolic disorders in humans. The present study, by improving considerably on our knowledge on the
mode of action and the active site structure could help design novel inhibitors to treat disorders involving an
increased activity of iPLAβ.
Regarding cPLAα, our study shows that this enzyme hydrolyzes either the sn-1 or sn-2  ester  bond  of  a  GPL
depending on the fatty acyl residues present in the substrate, and that this is most probably due to promiscuous
(“sloppy”)  binding of  the substrate’s  acyl  chain to  the active site  of  cPLA2α.  This,  along with other  data  on the
structure of the active site of cPLAα should be very helpful in designing new, more efficient inhibitors for this
enzyme which plays a key role in the release of AA, the precursor of prostaglandins and other second messengers
in mammalian cells.
In summary, the present data should be helpful for basic research attempting to resolve the biological functions of
mammalian PLAs. In addition, they should also assist in studies attempting to develop novel drugs targeting the
PLAs involved in several common metabolic diseases or disorders.
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9. CONCLUSIONS
Substrate specificities of different PLAs were studied in this thesis. The major conclusions drawn were:
1. In the first study, a mass-spectrometric high-throughput assay was developed which allows us to
monitor the hydrolysis of a multitude of GPL molecular species simultaneously. Specificities of three
different sPLA2s were elucidated by this method. The key finding in this study was that efflux of the
GPL substrate from the bilayer largely determines the rate of hydrolysis. In micelles, accommodation
of the GPL acyl chains in the catalytic active site seems to contribute to substrate specificity.
2. Our second study gives the first experimental evidence that efflux of the substrate from the bilayer is
the rate-limiting factor in the hydrolysis of GPL molecules by iPLAβ. We observed that the activity of
the enzyme correlates inversely with the hydrophobicity of the substrate.
3. In the final study on cPLA2α, the key finding is that accommodation of the substrate molecule in the
active site of the enzyme is crucial for the preferential hydrolysis of AA-containing GPLs along with
efflux of the substrate from the bilayer whereas in the case of GPL substrate lacking AA, efflux from
the bilayer seemed to be determing the rate of hydrolysis.
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